Hualan Biological Engineering,Inc. Company Profile - Aug 14, 2011

Document Sample
Hualan Biological Engineering,Inc. Company Profile - Aug 14, 2011 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Hualan Biological Engineering,Inc.
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Chinese Renmimbi

                                 Wright Quality Rating:BAA20                               Key Data

   Hualan Biological Engineering, Inc. is principally engaged in the research and          Ticker:
   development, production and sale of blood products and vaccine products. The            002007
   Company mainly provides human albumin, intravenous gammaglobulin, influenza
   vaccines and other products. The Company's products also include human                  2010 Sales:
   immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin,
                                                                                           1,261,621,000
   human immunoglobulin (pH4) for intravenous injection, human coagulation factor VIII,
   human prothrombin complex, human surgical lyophilized fibrin sealant and human
   thrombin lyophilized for external use. The Company distributes its products in the      Major Industry:
   domestic market and to the overseas markets.                                            Drugs, Cosmetics & Health
                                                                                           Care
                       Stock Chart                                  Officers
                                                               Chairman & General
                                                                    Manager                Sub Industry:
                                                                     Kang An               Ethical Drug Manufacturers

                                                               Chief Financial Officer     Country:
                                                                    Qiping Wang            China

                                                                                           Currency:
                                                                                           Chinese Renmimbi

                                                                                           Fiscal Year Ends:
                                                                                           December

                                                                                           Employees
                                                                                           820

                                                                                           Exchanges:
                                                                                           SZN

            Stock Price (8/12/2011): 26.32                                                 Share Type:
               Recent stock performance                                                    A Shares
                  1 Week        4.6%
                  4 Weeks     -21.5%
                                                                       
				
DOCUMENT INFO
Description: Hualan Biological Engineering, Inc. is principally engaged in the research and development, production and sale of blood products and vaccine products. The Company mainly provides human albumin, intravenous gammaglobulin, influenza vaccines and other products. The Company's products also include human immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin, human immunoglobulin (pH4) for intravenous injection, human coagulation factor VIII, human prothrombin complex, human surgical lyophilized fibrin sealant and human thrombin lyophilized for external use. The Company distributes its products in the domestic market and to the overseas markets.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.